MAYER HOLDINGS(01116.HK):訴訟下的非正審禁制令濟助申請已被駁回
格隆匯1月20日丨MAYER HOLDINGS(01116.HK)公佈,於2022年1月10日,公司收到香港高等法院發出的聆訊通知,公司(作為原吿人)於2022年1月6日針對前董事會主席兼執行董事徐立地先生及非執行董事王東奇先生(連同徐先生統稱被吿人,彼等現正暫停職務)(作為被吿人)存檔的非正審強制令申請(HCA17/2022)將於2022年1月17日進行聆訊。
於2022年1月20日,公司收到香港高等法院發出的命令蓋章文本,表示該訴訟下的非正審禁制令濟助申請已被駁回。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.